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Introduction: National data on 
maintenance dialysis are important for 
treatment planning. Aim: To describe 
the results of the dialysis census of the 
Brazilian Society of Nephrology for 2011 
and observed trends from 2000 to 2011. 
Methods: A survey was conducted using 
questionnaire filled online by the dialysis 
units, with July as reference month for 
estimates. From a total of 645 units, 
353 (54.9%) responded to the survey. 
Results: The estimated number of patients 
on dialysis in Brazil was 91,314 in 2011 
(42,629 in 2010; 92,091 in 2011). For 
approximately 85% of the patients the 
treatment was provided by the Brazilian 
Unified Health Care System. The 
estimated prevalence and incidence rates 
in 2011 were 475 and 149 maintenance 
dialysis patients per million population, 
respectively. For prevalent patients, 
90.6% were on hemodialysis, 31.5% 65 
years of age or older, 28% diabetic and 
35.5% (n = 32,454) on waiting list for 
transplantation in 2011. The estimated 
number of patients starting dialysis in 
2011 was 28,680 (18,972 in 2010) and 
annual mortality rate 19.9% (17.9% in 
2010). Conclusions: The data indicate 
pronounced increase in the dialysis 
population across the years in Brazil 
with a trend for stabilization in the last 
two years. The reason for the increase 
in incidence and mortality in 2011 
deserves investigation. A large number 
of patients were on waiting list for renal 
transplantation. By providing a picture of 
the situation and trends on maintenance 
dialysis treatment in Brazil the census 
is useful to guide resources allocation 
and interventions to improve treatment 
quality.
Chronic Dialysis in Brazil - Report of the Brazilian Dialysis 
Census, 2011
AbstrAct
Keywords: Brazil, censuses, dialysis, 
epidemiology, renal insufficiency, chronic.
IntroductIon
For over 10 years, the Brazilian Society 
of Nephrology (BSN) has organized an 
annual national census of patients with 
chronic renal disease on a chronic dialysis 
program. This information has enabled a 
better understanding of various epidemio-
logical aspects of chronic dialysis patients 
in the country, facilitated dialogue among 
the various sectors involved in providing 
this treatment, and guided the planning of 
care for these patients. This fundamental 
society accomplishment occurred with the 
voluntary cooperation of dialysis units 
across the country. In this report, we pres-
ent data concerning patients on dialysis as 
of July 1, 2011.
Methods
In July 2011, a survey of patients with 
chronic kidney disease in an outpatient 
dialysis program was conducted in all 687 
dialysis units in the country registered in 
the BSN. During the second semester of 
2011, a questionnaire was published on 
the BSN website (http://www.sbn.org.br/
index.php?censoAdmAtual&menu=24), 
and all dialysis units in the country were 
asked to complete it online. A reminder 
was sent monthly until the end of the data 
collection period (December 2011) to all 
units not responding to the survey. When 
necessary, data were confirmed by a BSN 
secretary via telephone call to the unit in 
question. This occurred in approximately 
15% of the units. Questions on the so-
ciodemographic, clinical, laboratory, and 
treatment aspects referred to patients un-
dergoing dialysis as of July 1, 2011. The 
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data regarding mortality and entry of new dialysis pa-
tients were collected till the month of July 2011, and 
were then estimated for the rest of the year.
Of the 687 dialysis units registered in the BSN in 
July 2011, 643 had an active program for chronic di-
alysis treatment and 353 (54.9%) of these units com-
pleted the survey (Table 1). Data were collected from 
50,128 patients undergoing treatment in the 353 di-
alysis units that participated in this survey. The units 
presented the data as group answers, i.e., the answers 
were given by indicating the number of patients in 
the unit that corresponded to the characteristics ques-
tioned. Therefore, the data should be interpreted as 
representative of the average characteristics of pa-
tients and treatment practices in each dialysis unit. 
The national data were estimated by considering the 
expected numbers in the centers that did not respond 
to the survey according to its regional location. The 
average number of patients expected in the region was 
assigned to each of these units. Population estimates 
from Brazil and every region of the country used in 
the calculations of prevalence and incidence rates 
were made from updated estimates of the Brazilian 
Institute of Geography and Statistics for July 2011. 
Using the pooled data, we estimated the percentage of 
patients outside the recommended target indices1,2 for 
dialysis dose (for Kt/V or urea reduction ratio) and 
serum albumin, phosphorus, parathyroid hormone 
(paratohormônio) (PTH), and hemoglobin.
results
Figure 1 shows the distribution of the units that re-
sponded to the census by region. The proportion of 
units that responded compared to the total number 
of units was similar between the various regions of 
the country, mostly located in the Southeast, followed 
by the South and Northeast. Of the 353 units with 
chronic dialysis programs that responded to the ques-
tionnaire, 91.5% had an agreement with the Brazilian 
Unified Health Care System (SUS) (Sistema Único de 
Saúde) and 75.6% had agreements with other private 
healthcare insurance organizations. Of this patient 
population, 84.9% was reimbursed by the SUS and 
15.1% was reimbursed by private health insurance 
companies.
tAble 1 general data frOm the dialysis unit resPOnses
 tO the census regarding Patients On   
 chrOnic dialysis (2011 census)
Number of units with a chronic dialysis program 643
Units with a chronic program that responded 
to the survey, N (%)
353 
(54.9)
Type of unit, %
Private/nonprofit/public 71/20/9
Satellite/hospital 49/51
University/non-university 17/83
Unit occupancy rate, % 82
% of units that treat patients with Acute renal 
lesion
72
Chronic kidney disease on dialysis 82
Number of patients in the 353 units 50,128
Estimated total number of dialysis patients in 
the country
92,091
Brazilian population in January 2011 (IBGE) in 
millions
190.73
IBGE: Brazilian Institute of Geography and Statistics.
Figure 1. Dialysis units that responded to the 2011 census (n = 
353) divided by region: South - Southeast - Northeast - Midwest 
- North.
Figure 2 shows the estimated total number of 
patients on dialysis in Brazil per year from 2000 to 
2011. The number has increased gradually over the 
years, from 42,695 in 2000 to 91,314 in 2011, the 
latter of which was constant with 2010. More than half 
of these patients were located in the southeast region 
of Brazil. The prevalence rate of dialysis in 2011 
was 475 patients per million population (pmp) 
and varied by region from 279 patients pmp in 
the northern region to 583 patients pmp in the 
southeast region (Figure 3). An estimated 26,680 
patients started this treatment in Brazil in 2011, 
corresponding to an incidence rate of 149 patients 
pmp (Figure 4). Approximately 50% of patients (n = 
14,622) started treatment in the southeast region. The 
annual incidence of treatment ranged from 68 pmp 
in the northern region to 201 pmp in the midwest 
region (Figure 5). These estimates are substantially 
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higher than those observed in 2010, during which 
period 18,972 patients started treatment (100 patients 
pmp).3
Figure 2. Estimated number of patients on dialysis in the country 
per year (2011 census).
Figure 3. Estimated prevalence of dialysis patients in Brazil by 
region (2011 census).
Figure 4. Estimated absolute number of new patients in Brazil by 
region (2011 census)
The percentages of dialysis patients aged ≤ 18 
years, between 18 to 64 years, 65–80 years, and >80 
years were 1.6%, 66.9%, 27.2%, and 4.3%, respec-
tively. Fifty-seven percent of these patients were male.
In July 2011, 90.6% of chronic dialysis patients 
Figure 5. Estimated incidence of patients on dialysis in Brazil by 
region (census 2011).
were being treated with hemodialysis and 9.4% were 
treated with peritoneal dialysis, and automated peri-
toneal dialysis (APD) was the predominant treatment. 
Table 2 shows the patient distribution according to 
dialysis type and paying agency. A higher percent-
age of patients reimbursed by private health insur-
ance underwent daily hemodialysis and peritoneal 
dialysis treatments, particularly APD, compared with 
those reimbursed by the SUS. A total of 8.7% of the 
SUS patients underwent peritoneal dialysis compared 
to 12.7% of the patients covered by private health 
insurance.
tAble 2 Patient distributiOn accOrding tO dialysis 
 tyPe and Payment sOurce (2011 census)
Modality SUS N (%)
Non-SUS 
N (%)
Total N 
(%)
Conventional 
HD
38.703 
(91.0)
6.475 
(85.3)
45.178 
(90.1)
Daily HD (> 
4×/week)
113 (0.3) 144 (1.9) 257 (0.5)
CAPD 1.703 (4.0) 307 (4.0) 2.010 (4.0)
APD 1.967 (4.6) 654 (8.6) 2.621 (5.2)
IPD 54 (0.1) 8 (0.1) 62 (0.1)
Total
42.540 
(100)
7.588 (100)
50.128 
(100)
The most frequent causes of the renal disease were 
hypertension (35%) and diabetes (28%) (Figure 6).
The prevalence of positive serology for hepatitis 
B and C in patients on chronic dialysis in Brazil was 
5.5% and 1.1%, respectively; for human immuno-
deficiency virus (HIV), the rate was 0.8%. In 2010, 
the prevalence of positive serology for hepatitis C, 
hepatitis B, and HIV was 5.8%, 1.1%, and 1.2%, 
respectively.
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The estimated percentage of patients on hemodi-
alysis with central venous access (temporary or per-
manent) was 14.2%. The monthly rate of hospitaliza-
tion was 6.1% in the patients studied (n = 50,128) 
in July 2011. With regard to the recommended labo-
ratory indices for patients on dialysis,1,2 among the 
hemodialysis patients, 20% had a Kt/V < 1.2 or urea 
reduction ratio < 65%, 14.8% had serum albumin < 
3.5 g/dL, 34.9% had serum phosphorus > 5.5 mg/dL, 
30.6% had PTH > 300 pg/mL, and 16.8% had PTH 
< 100 pg/mL, and 39.3% had hemoglobin < 11 g/dL 
(Figure 7).
The estimated number of deaths in 2011 was 
18,187, corresponding to a crude mortality rate (with 
the dialysis population as of July 2010 in the denomi-
nator) of 19.9% during the year. This rate is reduced 
to 15.2% when the value for all patients at risk in the 
year (who underwent dialysis during the year) is in 
the denominator. Figure 9 shows the crude mortality 
rates in the years 2008–2011.
Figure 6. Underlying diagnosis of patients on dialysis (census 
2011): HBP - DM - GNC - Polycystic Kidneys - Other - Undefined.
Figure 7. Percentage of patients whose examinations did not 
conform with the recommended indices, 2010–11 (census 2011).
Figure 8 shows the breakdown of medications pre-
scribed for these patients: erythropoietin, 80%; intra-
venous iron, 53%; vitamin D, 31%; sevelamer, 37%; 
and cinacalcet, 1.4%.
The estimated number of patients registered on 
the transplant waiting list in July 2011 was 32,454 
(35.5%).
Figure 8. Percentage of patients with selected prescription 
medications, 2010–11 (census 2011).
Figure 9. Crude mortality rates, 2008–2011.
dIscussIon
In this report, we discuss the status of dialysis units 
and the patients undergoing dialysis treatment in 
Brazil using data from the Brazilian dialysis census 
from July 2011. The results are based on data from 
the units that completed the questionnaires, repre-
senting approximately 55% of the dialysis units in 
the country. The percentage of responses in 2011 was 
similar to that in 2010 and lower than that in 2009, 
when approximately 66% of the centers responded 
to the census.3 This highlights the need to improve 
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the data collection methodology, which became ex-
clusively “online” in 2010, and the continuing search 
for greater unit collaboration. The distribution of 
units that responded is similar to the distribution of 
the total dialysis units by country region, allowing us 
to make inferences about the national generalizabil-
ity of the results. The estimates suggest an increase 
in the number of new patients and a stabilization of 
the prevalence rate of dialysis treatment in 2011 com-
pared to 2010. Considering the history of the census, 
this trend line does not allow us to define a real de-
crease in the growth rate of the dialysis population 
in Brazil. Our annual estimates should be interpreted 
with caution due to the variable percentage of re-
sponses from the units and the differences in some of 
the questionnaire answers that require further valida-
tion. In recent years, studies in the United States and 
other developed countries in Europe and Asia report-
ed a steady increase in the prevalence rate of dialysis, 
although the incidence of new patients on dialysis has 
grown little or shown a tendency to stabilize.4
The overall prevalence rate of dialysis (475 pmp) 
should be added to the rate of transplanted patients 
to obtain the actual rate of renal replacement therapy, 
which can rise to 650–700 pmp depending on the 
number patients with a functioning renal graft. The 
rate of renal replacement therapy in Brazil is lower 
than that in countries such as Chile, Uruguay, and de-
veloped countries in Europe, which is approximately 
1000 pmp, and in the US, which was 1,750 pmp in 
2008.4 In addition, there are large regional varia-
tions in Brazil, and the rate in the southeast region, 
for example, should be very close to that of devel-
oped countries. Approximately 28,000 patients (149 
pmp) initiated chronic dialysis treatment in 2011. 
As with prevalence rates, we observed large regional 
variations in incidence rates. The actual incidence rate 
should be obtained by adding the preemptive trans-
plant recipients, which would make it similar to that 
observed in many European countries and lower than 
that in the US (362 pmp) and Japan (288 pmp).4
The observation of 90.6% of patients on mainte-
nance hemodialysis is similar to that observed in pre-
vious censuses. This highlights the higher percentage 
of patients on APD among those subsidized by private 
health insurance companies, and the contribution of 
daily hemodialysis as a therapeutic modality, which 
decreased compared to 2010. Hypertensive nephrop-
athy and diabetes are the major underlying diseases. 
The prevalence of hepatitis C continues to decrease, 
and those of hepatitis B and HIV are stable. The per-
centage of patients whose examinations did not con-
form with the international guidelines1,2 was gener-
ally similar for all measured indicators relative to the 
year 2010. The prevalence of anemia reached 39% 
despite the use of erythropoietin and intravenous iron 
in the vast majority of patients. The recent preconiza-
tion of a lower range of values for hemoglobin should 
be further analyzed, which will certainly decrease the 
percentage of patients with low values.5 A high per-
centage of patients with anemia and increased levels 
of phosphorus and PTH compared to targets recom-
mended in guidelines have also been observed in other 
European countries, the US, and Japan.6,7 Lack of ad-
equacy observed in the BSN census data for the con-
trol of the indicators of disorders of mineral metabo-
lism occurs despite the high percentage of patients in 
whom sevelamer (37%) and vitamin D (31%) were 
prescribed as well as the recent start of prescription 
of cinacalcet in dialysis units across the country. The 
crude mortality rate increased consistently compared 
with previous years, which requires further study and 
consideration.
Some hypotheses for these findings can be raised, 
which include difficulties related to the public health 
system, non-achievement of treatment quality goals, 
poor prognostic profile of patients (comorbidities, 
handling pre-dialysis, age), among others. In the last 
year, compared to 2010, the percentage of patients 
with diabetic nephropathy was stable and there was a 
slight increase in the proportion of elderly undergoing 
dialysis; however, more data are required to analyze 
mortality in greater detail. Despite this increase, the 
increased mortality of patients undergoing dialysis in 
Brazil remains lower than that in North America.4
Generalizations of these study findings should be 
made with caution due to the relatively small percent-
age (relativamente reduzido) of units that responded, 
differences among centers in the data collection meth-
odology, and the lack of response validation.
conclusIons
The BSN census is an initiative of fundamental impor-
tance for the understanding of dialysis treatment in 
Brazil. This report continues to aid the process of im-
proving the treatment provided to patients with end-
stage chronic kidney failure as well as the national 
planning policy for chronic dialysis treatment.
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